Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ferry Ossendorp

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
Cell Reports|October 12, 2022
Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITABrett J Hos, Elena Tondini, Marcel G M Camps, et al.
Nature Communications|January 3, 2024
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumorsJim Middelburg, Marjolein Sluijter, Gaby Schaap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell deathTetje C van der Sluis, Suzanne van Duikeren, Suzanna Huppelschoten, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.
Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Oncotarget|August 27, 2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patientsGijs G Zom, Marij J P Welters, Nikki M Loof, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
ACS Chemical Biology|May 8, 2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified EpitopesAnouk M F van der Gracht, Mark A R de Geus, Marcel G M Camps, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibilityPeter Boross, Victoria L Arandhara, Javier Martin-Ramirez, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
Cell Reports|October 12, 2022
Cancer-specific T helper shared and neo-epitopes uncovered by expression of the MHC class II master regulator CIITABrett J Hos, Elena Tondini, Marcel G M Camps, et al.
Nature Communications|January 3, 2024
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumorsJim Middelburg, Marjolein Sluijter, Gaby Schaap, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 16, 2014
Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell deathTetje C van der Sluis, Suzanne van Duikeren, Suzanna Huppelschoten, et al.
European Journal of Immunology|July 10, 2013
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activationRodney A Rosalia, Esther D Quakkelaar, Anke Redeker, et al.
Science Translational Medicine|March 13, 2020
Dendritic cells dictate responses to PD-L1 blockade cancer immunotherapyMaud Mayoux, Andreas Roller, Vesna Pulko, et al.
Journal of Autoimmunity|June 4, 2011
Discovery of low-affinity preproinsulin epitopes and detection of autoreactive CD8 T-cells using combinatorial MHC multimersWendy W Unger, Jurjen Velthuis, Joana R F Abreu, et al.
Oncotarget|August 27, 2016
TLR2 ligand-synthetic long peptide conjugates effectively stimulate tumor-draining lymph node T cells of cervical cancer patientsGijs G Zom, Marij J P Welters, Nikki M Loof, et al.
The Journal of Clinical Investigation|September 20, 2008
CTLs are targeted to kill beta cells in patients with type 1 diabetes through recognition of a glucose-regulated preproinsulin epitopeAnia Skowera, Richard J Ellis, Ruben Varela-Calviño, et al.
ACS Chemical Biology|May 8, 2018
Chemical Control over T-Cell Activation in Vivo Using Deprotection of trans-Cyclooctene-Modified EpitopesAnouk M F van der Gracht, Mark A R de Geus, Marcel G M Camps, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 5, 2011
The inhibiting Fc receptor for IgG, FcγRIIB, is a modifier of autoimmune susceptibilityPeter Boross, Victoria L Arandhara, Javier Martin-Ramirez, et al.
Pageof 16